San righting cancer treatment of lung cancer chemotherapy.docVIP

 PAGE \* MERGEFORMAT 11 San righting cancer treatment of lung cancer chemotherapy [Abstract] At present lung cancer incidence and mortality has become the fastest growing, serious harm to human health and life of the cancer. Fatality rate of lung cancer deaths in the city now ranks the first place. The majority of patients already in the late stage when diagnosed. Loss surgery opportunity to cure. can only palliative chemotherapy. but because of chemotherapy side effects, particularly bone marrow suppression induced neutropenia, so that patients be interrupted treatment, or even cause life-threatening infections refractory [1 ]. the general survival of only 8-10 months. In order to improve efficacy, the maximum extension of survival. our department from December 2007 -2009 in December, according to the staging of lung cancer patients, histological type, physical state, etc. cancer using self Powder Fuzheng treatment of lung cancer chemotherapy 300 patients achieved satisfactory clinical efficacy, many symptoms such as: cough, sputum with blood, loss of appetite, Shenpi fatigue, neutropenia, and physical condition are has clearly improved. are summarized below. [Keywords:] centralizer neutropenic lung cancer bulk 1 Clinical data 300 cases of advanced lung cancer patients were accepted in our department and the combined bulk of Fuzheng anti-cancer chemotherapy combination treatment. All cases were confirmed by histopathology of lung cancer. Including non-small cell lung cancer (NSCLC225 cases, accounting for 75%. Small cell lung cancer (SCLC75 cases, accounting for 25%. 200 cases were randomly divided into treatment group and control group of 100 cases. 152 cases in which treatment of male and female 48 cases, the average age of 61.6 years. control group, 71 male and female 29 cases, arrogance  Kyung ? 3.5 years old. All the cases according to the International Anti-Cancer Association (UICCTNM of disease classification is III-IV lung cancer perio